Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma

NCT01947062 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Squamous Cell Carcinoma of the Lung
Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung

Interventions

DRUG: Intravenous Cisplatin & etoposide
DRUG: Intravenous Cisplatin & etoposide along with oral cyclophosphamide

Sponsor

Swami Rama Cancer Hospital and Research Institute